Back | Next |
home / stock / petx / petx message board
Subject | By | Source | When |
---|---|---|---|
Engaged Capital updates on its portfolio holdings | biotech_researcher | investorshub | 08/14/2018 9:27:55 PM |
Aratana Therapeutics ($PETX) | terry hallinan | investorshub | 08/13/2018 12:27:39 PM |
Darn nice bounce from the earnings release low... | biotech_researcher | investorshub | 08/07/2018 1:57:24 PM |
Blue, Biotech; | terry hallinan | investorshub | 08/03/2018 8:42:10 PM |
Blue, I review Aratanas PR, and your post | biotech_researcher | investorshub | 08/03/2018 2:45:36 PM |
Blue, my point is these sales numbers are | biotech_researcher | investorshub | 08/03/2018 1:36:43 PM |
Not confused at all. Subtract $3.7Mil to Elanco | BlueRayn | investorshub | 08/03/2018 1:26:24 PM |
Im looking to re-enter $PETX again. I bought | biotech_researcher | investorshub | 08/03/2018 10:32:30 AM |
Blue, you maybe confused as here is the | biotech_researcher | investorshub | 08/03/2018 9:42:00 AM |
With quarterly revenue declining in Q2 5% from | terry hallinan | investorshub | 08/03/2018 9:40:17 AM |
What? The qtrly rev drop was due to | BlueRayn | investorshub | 08/03/2018 9:20:36 AM |
With quarterly revenue declining in Q2 5% from | biotech_researcher | investorshub | 08/03/2018 2:42:36 AM |
New Fans Update. :-) | terry hallinan | investorshub | 07/18/2018 6:46:44 PM |
$PETX appears to have no fans. | terry hallinan | investorshub | 07/03/2018 7:37:32 AM |
$PETX appears to have no fans.. The sales | biotech_researcher | investorshub | 07/02/2018 2:39:39 PM |
Prostaglandin E2 Exerts Catabolic Effects in Osteoarthritis Cartilage: | terry hallinan | investorshub | 06/20/2018 7:24:25 PM |
Aratana Therapeutics Files for FDA Approval of NOCITA | terry hallinan | investorshub | 06/01/2018 3:10:57 PM |
Yes, I wondered about Lowell as well. But, | biotech_researcher | investorshub | 05/22/2018 12:29:01 AM |
Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robins | terry hallinan | investorshub | 05/21/2018 10:20:04 PM |
Not a single large successful company was a sellout. | terry hallinan | investorshub | 05/06/2018 4:47:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Aratana Therapeutics Inc. Company Name:
PETX Stock Symbol:
NASDAQ Market:
Aratana Therapeutics Inc. Website:
LEAWOOD, Kan. , July 16, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and vote...
TÜBINGEN, Germany and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that Timothy Wright, M.D. and Craig Tooman were elected as independent directors to CureVac’s Supervisory ...
LEAWOOD, Kan. , June 11, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food and Drug Administration's Center for Veteri...